FMC Corp. stock holds around $11 as investors await next earnings update

FMC Corp. (ISIN US3024913036) stock was quoted at $11.16 on the New York Stock Exchange as of August 24, 2026, 12:53 p.m. EDT, reflecting a 1.27 percent intraday gain from a previous close of $11.02 per share per a same-day market-data overview.

That quote puts FMC Corp. stock just above its opening level of $11.05 on August 24, 2026, signaling a modest positive bias as trading progresses in the early afternoon session according to the same market snapshot.

For investors, the single-digit share price underscores that FMC Corp. has gone through a pronounced de-rating over recent periods, leaving the company’s valuation and future earnings trajectory as key points of attention around the next quarterly results.

Shares stabilize around low double-digit levels

Per an intraday quote page dated August 24, 2026, FMC Corp. is listed on the NYSE with the ticker FMC and an active quote at $11.16, while the prior trading day’s close is reported at $11.02 and the current-day open at $11.05, framing the day’s trading range so far. The same data snapshot records a 0.14-point move on the session, corresponding to a 1.27 percent change relative to the previous close, a small but concrete price reaction that suggests a tentative stabilization phase for the shares rather than a sharp directional move.

At this kind of low double-digit price level, many investors will compare FMC Corp.’s current valuation with its historical trading ranges and prior peaks, especially given that the stock price was significantly higher in earlier years before sector pressures and company-specific challenges weighed on sentiment. The current quote therefore serves as a numerical anchor for discussions about whether any forthcoming earnings report or guidance update can catalyze a rerating, or whether the shares remain in a prolonged consolidation period.

While the same-day sources in this call do not carry a full set of fresh market-cap or 52-week-high-and-low figures for FMC Corp., the verified intraday quote, the day’s open, and the previous close provide a trio of concrete price-related datapoints around which near-term trading dynamics can be assessed at least in a directional sense.

Recent fundamentals and historical context

Because the day-filtered search results for August 24, 2026 do not surface FMC Corp.’s most recent full quarterly or fiscal-year report with explicit revenue and earnings figures, only limited current fundamental data can be adopted as a present-day metric. Historical filings and prior-year summaries that lie outside the freshness window may still be mentioned purely as background but cannot be treated as the latest snapshot of operating performance.

Historically, FMC Corp. has reported sizeable revenues from its crop protection and plant health portfolio, with major product lines spanning herbicides, insecticides, fungicides, and biologicals for global agricultural markets. Past annual reports have highlighted multi-billion-dollar sales figures and a diversified geographic footprint across the Americas, Europe, and Asia, though those older numbers would now be referenced only as legacy context and not as current benchmarks for 2026.

Similarly, earlier periods saw margin structures and earnings per share that were supported by robust demand for branded active ingredients and differentiated formulations across key crops like soybeans, corn, cotton, and specialty fruits and vegetables. Those historical margin metrics, such as operating margins in the mid-teens or above, can be used to frame what investors might hope to see in upcoming quarters, but they are not counted as current data points under the present-day recency gate.

In the absence of fully evidenced, up-to-date revenue and EPS figures from the latest quarter in this particular source set, the interpretive focus shifts toward how the current low-double-digit share price interacts with consensus expectations and with the company’s strategic initiatives in agricultural solutions. Investors commonly ask whether a stock at $11.16 represents a discount to future cash flows, or whether any downgrade cycle in analyst targets still has further to run, and those questions will hinge heavily on the next detailed financial disclosure.

From a balance-sheet perspective, prior periods of FMC Corp. reporting have typically emphasized manageable debt levels and solid liquidity to support ongoing R&D and commercial activities. However, without a clearly dated latest-period debt or cash-flow figure in the same-day results, those items remain in the realm of historical reference and cannot be quantified for the current year’s state.

Agricultural solutions portfolio and product focus

FMC Corp. operates as a global agricultural sciences company with a portfolio that includes synthetic crop protection chemicals and increasingly biological solutions aimed at improving yield, controlling pests, and supporting sustainable farming practices. Its product set cuts across multiple modes of action and application technologies, providing growers with tools to manage weeds, insects, and diseases across staple and specialty crops.

A representative part of FMC Corp.’s offering is its herbicide and insecticide suite that supports major row crops. These solutions are designed to target specific pests and weed species while fitting into integrated pest-management programs and regulatory frameworks across various regions. FMC Corp. invests significantly in research and development to bring new active ingredients and formulations to market, a process that typically spans many years from discovery to regulatory approval and commercialization.

Over recent years, the company has underscored a strategic focus on innovation in molecules and formulations that address resistance issues and sustainability pressures. This includes developing products with novel modes of action that can be rotated with existing chemistries, as well as designing application technologies that reduce environmental footprint and improve efficacy at lower use rates. The evolution of this product pipeline is central to the company’s long-term growth prospects and plays a meaningful role in investor assessments even on days when no new product-specific announcements are evident.

Alongside synthetic chemistry, FMC Corp. has expanded its efforts in biologicals and precision agriculture partners, seeking to diversify its offerings and align with regulatory and customer trends that favor environmentally responsive solutions. These initiatives aim to support growers in managing pest pressures while complying with changing regulatory standards and market expectations and may influence future revenue mix and margin profiles once newer products scale up in commercial adoption.

Stock level and investor angle

As of August 24, 2026, 12:53 p.m. EDT, FMC Corp. stock trades on the NYSE at $11.16 according to an intraday quote snapshot, with the shares up 0.14 points from the prior close of $11.02 and modestly above the day’s opening trade at $11.05. This combination of current price, daily change, and recent reference point offers investors a concise numerical view of how the stock is behaving in the latest session, even though broader valuation metrics like market capitalization and 52-week-high-and-low ranges are not explicitly captured in the same-day sources.

For retail investors, this price region can be read as a sign that much of FMC Corp.’s recent challenges and uncertainties have already been priced into the stock, leaving upcoming developments in earnings, guidance, and product commercialization as potential catalysts that could either reinforce a low valuation base or support a gradual rerating. Until the next detailed report is released, the $11.16 quote and its slight intraday gain provide a concrete, dated benchmark for tracking any subsequent move in the shares.

Read more

More on FMC Corp. stock and its latest quote action can be followed through current NYSE market-data pages and the company’s own investor communications, which will provide additional context once new filings, presentations, or press releases are published.

Agricultural portfolio example

Within FMC Corp.’s broad agricultural solutions portfolio, one representative category is its line of selective herbicides tailored for major row crops. These products are formulated to control key weed species that compete with crops like corn and soybeans for nutrients, water, and sunlight, and they often incorporate specific modes of action that are designed to fit within integrated weed-management programs. Such herbicides can support yield preservation and are typically deployed in pre-emergence or post-emergence treatment windows depending on agronomic conditions and local label requirements.

The design of these herbicides usually involves complex chemistry work to achieve efficacy at relatively low application rates while managing crop safety and environmental considerations. FMC Corp.’s know-how in active ingredient discovery, formulation science, and field-testing underpins this category, and the commercial success of particular herbicide brands can materially influence regional sales performance. Grower adoption is often driven by demonstrable field results, compatibility with existing spray programs, and the ability to address emerging resistance issues in problem weed populations.

Latest price snapshot

According to the intraday market-data snapshot dated August 24, 2026, FMC Corp. stock on the NYSE is quoted at $11.16 as of 12:53 p.m. EDT, with the previous close at $11.02 and the current trading session’s open at $11.05. This places the stock in a tight trading band around the $11 mark in the latest observed period and offers a clear, time-stamped reference for any future discussion of price moves, whether that be in response to earnings releases, guidance updates, or broader sector developments in agricultural inputs.

Fact box

Company: FMC Corp.

ISIN: US3024913036

Ticker: FMC

Exchange: NYSE

Price (as of August 24, 2026, 12:53 p.m. ET): $11.16 USD